| pubmed-article:9873712 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9873712 | lifeskim:mentions | umls-concept:C0002482 | lld:lifeskim |
| pubmed-article:9873712 | lifeskim:mentions | umls-concept:C0022634 | lld:lifeskim |
| pubmed-article:9873712 | lifeskim:mentions | umls-concept:C0559956 | lld:lifeskim |
| pubmed-article:9873712 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:9873712 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:9873712 | lifeskim:mentions | umls-concept:C1707271 | lld:lifeskim |
| pubmed-article:9873712 | lifeskim:mentions | umls-concept:C1513016 | lld:lifeskim |
| pubmed-article:9873712 | lifeskim:mentions | umls-concept:C0178696 | lld:lifeskim |
| pubmed-article:9873712 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:9873712 | pubmed:dateCreated | 1999-1-26 | lld:pubmed |
| pubmed-article:9873712 | pubmed:abstractText | A series of succinyl hydroxamate MMP inhibitors were prepared incorporating an aryl amino ketone moiety in place of the more typical C-terminal amino acid amides. Compounds of the C-terminal ketone series displayed potent inhibition of MMPs. Several compounds of the series were shown to be orally bioavailable. | lld:pubmed |
| pubmed-article:9873712 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9873712 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873712 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9873712 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9873712 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:MagocT JTJ | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:YUMM | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:GuoYY | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:MarcotteP APA | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:AlbertD HDH | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:MorganD WDW | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:DavidsenS KSK | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:SummersJ BJB | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:SheppardG SGS | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:BouskaJ JJJ | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:GoodfellowC... | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:FlorjancicA... | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:GieslerJ RJR | lld:pubmed |
| pubmed-article:9873712 | pubmed:author | pubmed-author:ElmoreII | lld:pubmed |
| pubmed-article:9873712 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9873712 | pubmed:day | 17 | lld:pubmed |
| pubmed-article:9873712 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:9873712 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9873712 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9873712 | pubmed:pagination | 3251-6 | lld:pubmed |
| pubmed-article:9873712 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:meshHeading | pubmed-meshheading:9873712-... | lld:pubmed |
| pubmed-article:9873712 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9873712 | pubmed:articleTitle | Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors. | lld:pubmed |
| pubmed-article:9873712 | pubmed:affiliation | Department 47J, AP-10, Abbott Laboratory, Abbott Park, Illinois 60064, USA. | lld:pubmed |
| pubmed-article:9873712 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:9873712 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9873712 | lld:pubmed |
